Israel’s MDClone Announces $15 Million in Funding

Healthcare IT startup MDClone announced today it has raised $15 million from OrbiMed Israel Partners and Lightspeed Venture Partners.

MDClone is introducing a new approach to healthcare data access, privacy, analytics, and research. The company’s platform enhances the utility of data. According to the company, its synthetic data engine offers the first solution on the market to eliminate the risk of releasing identifiable patient information when conducting healthcare analysis and research.

MDClone released its first product in February, 2017, and it already counts most of Israel’s healthcare system as customers. In January, 2018, the company signed its first major deal in the U.S. with Washington University School of Medicine in St. Louis. The funding will be used for ongoing development of the MDClone platform and for global expansion.